| Lung cancer with loss of BRG 1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features D Matsubara, Y Kishaba, S Ishikawa, T Sakatani, S Oguni, T Tamura, ... Cancer science 104 (2), 266-273, 2013 | 130 | 2013 |
| Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad D Matsubara, Y Kanai, S Ishikawa, S Ohara, T Yoshimoto, T Sakatani, ... Journal of Thoracic Oncology 7 (12), 1872-1876, 2012 | 121 | 2012 |
| Loss of YAP1 defines neuroendocrine differentiation of lung tumors T Ito, D Matsubara, I Tanaka, K Makiya, Z Tanei, Y Kumagai, SJ Shiu, ... Cancer science 107 (10), 1527-1538, 2016 | 102 | 2016 |
| Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes D Matsubara, T Niki, S Ishikawa, A Goto, E Ohara, T Yokomizo, ... Cancer science 96 (12), 844-857, 2005 | 99 | 2005 |
| Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition R Ibrahim, D Matsubara, W Osman, T Morikawa, A Goto, S Morita, ... Human pathology 45 (7), 1397-1405, 2014 | 93 | 2014 |
| Identification of cell-type-specific mutations in nodal T-cell lymphomas TB Nguyen, M Sakata-Yanagimoto, Y Asabe, D Matsubara, J Kano, ... Blood cancer journal 7 (1), e516-e516, 2017 | 92 | 2017 |
| A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion T Ikenoue, Y Terakado, H Nakagawa, Y Hikiba, T Fujii, D Matsubara, ... Scientific reports 6 (1), 23899, 2016 | 82 | 2016 |
| Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance A Goto, T Niki, L Chi‐pin, D Matsubara, Y Murakami, N Funata, ... Cancer science 96 (8), 480-486, 2005 | 74 | 2005 |
| Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells K Tominaga, T Shimamura, N Kimura, T Murayama, D Matsubara, ... Oncogene 36 (9), 1276-1286, 2017 | 72 | 2017 |
| The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma S Saito, K Morishima, T Ui, H Hoshino, D Matsubara, S Ishikawa, ... BMC cancer 15, 1-12, 2015 | 69 | 2015 |
| Integrated exome and RNA sequencing of dedifferentiated liposarcoma M Hirata, N Asano, K Katayama, A Yoshida, Y Tsuda, M Sekimizu, ... Nature communications 10 (1), 5683, 2019 | 59 | 2019 |
| Constitutive activation of c‐Met is correlated with c‐Met overexpression and dependent on cell–matrix adhesion in lung adenocarcinoma cell lines Y Nakamura, D Matsubara, A Goto, S Ota, O Sachiko, S Ishikawa, ... Cancer science 99 (1), 14-22, 2008 | 58 | 2008 |
| Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas D Matsubara, S Ishikawa, O Sachiko, H Aburatani, M Fukayama, T Niki The American journal of pathology 177 (5), 2191-2204, 2010 | 55 | 2010 |
| Heterogeneous expression of nestin in myofibroblasts of various human tissues Y Kishaba, D Matsubara, T Niki Pathology international 60 (5), 378-385, 2010 | 53 | 2010 |
| Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung T Yoshimoto, D Matsubara, T Nakano, T Tamura, S Endo, Y Sugiyama, ... Pathology international 65 (11), 595-602, 2015 | 49 | 2015 |
| Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma T Narahashi, T Niki, T Wang, A Goto, D Matsubara, N Funata, ... Histopathology 49 (4), 349-357, 2006 | 49 | 2006 |
| Immunohistochemical analysis of the expression of E‐cadherin and ZEB1 in non‐small cell lung cancer D Matsubara, Y Kishaba, T Yoshimoto, Y Sakuma, T Sakatani, T Tamura, ... Pathology international 64 (11), 560-568, 2014 | 48 | 2014 |
| Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells D Matsubara, S Ishikawa, S Oguni, H Aburatani, M Fukayama, T Niki Journal of Thoracic Oncology 5 (9), 1317-1324, 2010 | 46 | 2010 |
| HLA class I analysis provides insight into the genetic and epigenetic background of immune evasion in colorectal cancer with high microsatellite instability M Kawazu, T Ueno, K Saeki, N Sax, Y Togashi, T Kanaseki, K Chida, ... Gastroenterology 162 (3), 799-812, 2022 | 41 | 2022 |
| Inactivating mutations and hypermethylation of the NKX2‐1/TTF‐1 gene in non‐terminal respiratory unit‐type lung adenocarcinomas D Matsubara, M Soda, T Yoshimoto, Y Amano, Y Sakuma, A Yamato, ... Cancer science 108 (9), 1888-1896, 2017 | 39 | 2017 |
